Showing 1 - 2 results of 2 for search 'Annunziata MC', query time: 0.03s Refine Results
  1. 1
    Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration – A Case Report

    Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration – A Case Report by Martora F, Annunziata MC, Potestio L, Battista T, Ruggiero A, Megna M

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience

    Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience by Martora F, Megna M, Battista T, Potestio L, Annunziata MC, Marasca C, Villani A, Fabbrocini G

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: